BR9506564A - Processo para solubilizar ativos farmacêuticos de dificil solubilidade - Google Patents

Processo para solubilizar ativos farmacêuticos de dificil solubilidade

Info

Publication number
BR9506564A
BR9506564A BR9506564A BR9506564A BR9506564A BR 9506564 A BR9506564 A BR 9506564A BR 9506564 A BR9506564 A BR 9506564A BR 9506564 A BR9506564 A BR 9506564A BR 9506564 A BR9506564 A BR 9506564A
Authority
BR
Brazil
Prior art keywords
difficult solubility
pharmaceutical assets
solubilizing pharmaceutical
solubilizing
assets
Prior art date
Application number
BR9506564A
Other languages
English (en)
Inventor
Dabi Jamshed Dhabhar
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of BR9506564A publication Critical patent/BR9506564A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR9506564A 1994-01-24 1995-01-24 Processo para solubilizar ativos farmacêuticos de dificil solubilidade BR9506564A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18557694A 1994-01-24 1994-01-24
PCT/US1995/001018 WO1995019759A1 (en) 1994-01-24 1995-01-24 Process for solubilizing difficultly soluble pharmaceutical actives

Publications (1)

Publication Number Publication Date
BR9506564A true BR9506564A (pt) 1997-09-02

Family

ID=22681571

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9506564A BR9506564A (pt) 1994-01-24 1995-01-24 Processo para solubilizar ativos farmacêuticos de dificil solubilidade

Country Status (14)

Country Link
EP (1) EP0741560A1 (pt)
JP (1) JPH09508128A (pt)
CN (1) CN1138827A (pt)
AU (1) AU706890B2 (pt)
BR (1) BR9506564A (pt)
CA (1) CA2181241C (pt)
CZ (1) CZ210496A3 (pt)
FI (1) FI962948A (pt)
MX (1) MX9602955A (pt)
NO (1) NO963052L (pt)
NZ (1) NZ279443A (pt)
PL (1) PL315635A1 (pt)
SK (1) SK96196A3 (pt)
WO (1) WO1995019759A1 (pt)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998058637A1 (en) * 1996-06-20 1998-12-30 Mcneil-Ppc Acetaminophen and diphenhydramine analgesics
ZA975444B (en) * 1996-06-20 1998-12-21 Mcneil Ppc Inc Acetaminophen and meclizine hydrochloride analgesics
FR2751875B1 (fr) * 1996-08-05 1998-12-24 Scr Newpharm Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation
US5763449A (en) * 1996-08-07 1998-06-09 Ascent Pediatrics, Inc. Pleasant-tasting aqueous liquid composition of a bitter-tasting drug
US6365180B1 (en) * 1998-01-20 2002-04-02 Glenn A. Meyer Oral liquid compositions
ATE429210T1 (de) * 1998-01-20 2009-05-15 Applied Analytical Ind Inc Orale flüssige zusammensetzungen
US20020086878A1 (en) * 1999-01-11 2002-07-04 Douglas Joseph Dobrozsi Compositions having improved stability
US6846495B2 (en) 1999-01-11 2005-01-25 The Procter & Gamble Company Compositions having improved delivery of actives
US20020082307A1 (en) * 1999-01-11 2002-06-27 Dobrozsi Douglas Joseph Compositions having improved stability
US6211246B1 (en) * 1999-06-10 2001-04-03 Mcneil-Ppc, Inc. Rapidly absorbed liquid compositions
FR2796843B1 (fr) * 1999-07-29 2003-05-09 So Ge Val Sa Composition antipyretique concentree et stabilisee a usage veterinaire destine a etre incorporee a l'alimentation des animaux ainsi que procede d'incorporation de cette composition a l'eau de boisson d'animaux
US6251426B1 (en) 1999-09-02 2001-06-26 Banner Pharmacaps, Inc. Ibuprofen-containing softgels
DE10011032A1 (de) * 2000-03-07 2001-09-13 Bayer Ag Acetylsalicylsäure-Lösungen
KR20020069387A (ko) * 2001-02-26 2002-09-04 진양제약주식회사 호박산독실아민 조성물 및 이 조성물을 함유한 연질캅셀제제
MXPA04001026A (es) * 2001-07-31 2005-06-20 Wyeth Corp Formulacion de sucralosa para disimular sabores desagradables.
US7101572B2 (en) * 2001-12-07 2006-09-05 Unilab Pharmatech, Ltd. Taste masked aqueous liquid pharmaceutical composition
CN100379406C (zh) * 2003-09-22 2008-04-09 北京德众万全药物技术开发有限公司 一种难溶性药物微丸的制备方法及包含该微丸的制剂
CA2627292C (en) * 2005-10-26 2012-04-17 Banner Pharmacaps, Inc. Hydrophilic vehicle-based dual controlled release matrix system
DE102005053066A1 (de) 2005-11-04 2007-05-10 Basf Ag Verwendung von Copolymeren als Solubilisatoren für in Wasser schwerlöslichen Verbindungen
WO2007065846A2 (de) * 2005-12-09 2007-06-14 Basf Se Verwendung von polyvinyllactam-polyoxyalkylen-blockcopolymeren als solubilisatoren für in wasser schwerlösliche verbindungen
US8637076B2 (en) 2006-06-01 2014-01-28 Cima Labs Inc. Prednisolone salt formulations
JP2008184430A (ja) * 2007-01-30 2008-08-14 Ss Pharmaceut Co Ltd ソフトカプセル
CA2690490C (en) * 2010-01-19 2012-06-26 Accucaps Industries Limited Pharmaceutical formulations of loratadine for encapsulation and combinations thereof
CA2690488C (en) * 2010-01-19 2013-06-11 Accucaps Industries Limited Pharmaceutical formulations of naproxen for soft gel encapsulation and combinations thereof
PT3158991T (pt) 2010-01-28 2021-06-23 Eagle Pharmaceuticals Inc Formulações de bendamustina
CA2867295C (en) 2012-03-20 2020-08-11 Eagle Pharmaceuticals, Inc. Formulations of bendamustine
EP2827863B1 (en) 2012-03-20 2019-01-16 Eagle Pharmaceuticals, Inc. Liquid composition for use in a method of treating bendamustine-responsive conditions in patients requiring reduced volumes for administration
CA2898408C (en) 2013-02-28 2018-01-02 Pfizer Inc. Enhanced stability of novel liquid compositions
GB201506755D0 (en) * 2015-04-21 2015-06-03 Reckitt Benckiser Llc Novel pharmaceutical formulation
TWI586379B (zh) * 2015-06-29 2017-06-11 永信藥品工業股份有限公司 一種製作難溶藥物固體劑型的方法
US11278506B2 (en) 2015-10-09 2022-03-22 Rb Health (Us) Llc Pharmaceutical formulation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5141961A (en) * 1991-06-27 1992-08-25 Richrdson-Vicks Inc. Process for solubilizing difficulty soluble pharmaceutical actives

Also Published As

Publication number Publication date
CA2181241C (en) 2000-04-25
FI962948A0 (fi) 1996-07-23
PL315635A1 (en) 1996-11-25
NO963052D0 (no) 1996-07-22
NZ279443A (en) 1998-04-27
FI962948A (fi) 1996-07-23
MX9602955A (es) 1997-06-28
AU1607595A (en) 1995-08-08
WO1995019759A1 (en) 1995-07-27
AU706890B2 (en) 1999-07-01
JPH09508128A (ja) 1997-08-19
EP0741560A1 (en) 1996-11-13
SK96196A3 (en) 1997-03-05
CZ210496A3 (en) 1996-12-11
CA2181241A1 (en) 1995-07-27
CN1138827A (zh) 1996-12-25
NO963052L (no) 1996-09-24

Similar Documents

Publication Publication Date Title
BR9506564A (pt) Processo para solubilizar ativos farmacêuticos de dificil solubilidade
BR9503638A (pt) Composto processo para sua produção e formulação farmacêutica
BR9408463A (pt) Novos derivados de ginkgolide e processo para sua preparação
BR9504509A (pt) Composto processo para sua preparaçao e formulaçao farmaceûtica
BR9612135A (pt) Taxóides processo para sua preparação e composiç o farmacêutica
BR9306629A (pt) Processo para preparar derivados de triaza-ciclo-nonano
BR9704683A (pt) Processo de utilizar um sistema de jogo e aparelho para um sistema de jogo
BR9611986A (pt) Compostos processo para a preparação dos mesmos composição farmcéutica e utilização dos compostos
PT876444E (pt) Composicoes solventes parafinicas de elevada pureza e processo para a sua fabricacao
BR9407869A (pt) Combinaçao composiçao farmacêutica e processo para o tratamento de osteoporose
BR9508906A (pt) Processo e aparelho para executar transações diferidas
PT770615E (pt) Processo para a preparacao de di-haloazolopirimidinas
BR9708312A (pt) Derivados de 4-amino-pirimidina medicamentos contendo esses compostos sua aplicação e processo para sua fabricação
PT101165A (pt) Processo para a preparacao de inibidores duais sem sintese e sem ciclo-oxigenase
BR9503101A (pt) Processo e aparelho para fabricar tabletes
BR9306679A (pt) Processo para obtenção de lecitina
BR9606396A (pt) Derivados de camptotecin substituídos e processo para sua preparação
BR9404879A (pt) Processo e aparelho para beneficiamento de refrigerante
BR9101475A (pt) Composto,processo para sua obtencao,medicamento,processo para sua obtencao,e utilizacao de tal composto
BR9601294A (pt) Composto e processo para preparação do mesmo
BR9609533A (pt) Processo para preparação de 3-hidroxipirazóis n-substituídos
BR9301753A (pt) Processo para preparacao de produtos de adicao
PT877738E (pt) Processo para a preparacao de derivados de fenil-imidazolidina
BR9806081A (pt) Processo aperfei-oado de sintese de ur-ia e aparelho para o mesmo
BR9401524A (pt) Aparelho e processo para inspeção de recipientes

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal